Trial Profile
A prospective, observational cohort trial investigating relation between clinical response, golimumab level and anti-drug antibodies against TNF-inhibitors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 04 Dec 2015 New trial record